A genomic engineering technology independently developed by Ubigene can safely and in
highly efficient achieve precise integration and stable expression of exogenous DNA
without the need for viruses. This technology provides researchers with the safe,
stable, and highly expressed cell lines, accelerating the process of gene function
research, protein expression optimization, and candidate drug screening and evaluation.
Site-specific integration
Site-specific integration
Using advanced transposon system, the gene
expression cassette is integrated at a specific
site in the genome without the need for a virus,
achieving high-level expression.
Single copy
Single copy
Unique cell screening technology enables the gains of
monoclonal-like stable cell lines with single copy,
consistent genotype, and stable expression.